Bibliographic citations
Briones, A., Sandy, F. (2013). Prevalencia de dislipidemia en pacientes infectados con el VIH y en tratamiento antirretroviral de gran actividad atendidos en el Hospital Regional de Loreto, agosto a noviembre del 2012 [Tesis, Universidad Científica del Perú]. http://hdl.handle.net/20.500.14503/2121
Briones, A., Sandy, F. Prevalencia de dislipidemia en pacientes infectados con el VIH y en tratamiento antirretroviral de gran actividad atendidos en el Hospital Regional de Loreto, agosto a noviembre del 2012 [Tesis]. PE: Universidad Científica del Perú; 2013. http://hdl.handle.net/20.500.14503/2121
@misc{renati/1039020,
title = "Prevalencia de dislipidemia en pacientes infectados con el VIH y en tratamiento antirretroviral de gran actividad atendidos en el Hospital Regional de Loreto, agosto a noviembre del 2012",
author = "Sandy Barboza, Felipe",
publisher = "Universidad Científica del Perú",
year = "2013"
}
The general objective of this study was to determine the prevalence of dyslipidemia in patients infected by the Human Immunodeficiency Virus (HIV) and in Treatment Antiretroviral of High Activity as well as the impact that the use of the different schemes of antiretrovirals has on lipids in the period August to November 2012. methodology was Quantitative non-experimental descriptive, transversal, prospective, the sample was 209 Procitss patients from the H.R.L, both men and women with confirmed diagnosis of HIV infection, determining serum levels after fasting total cholesterol, HDL-c, LDL-c, VLDL-c and triglycerides for the diagnosis of dyslipidemia, as well as Data were also collected from the medical records (f ARGA, time and stage of disease). The results were: The frequency of dyslipidemia was 124 (59.3%) of these 92 men and 32 women; 176 (84.3%) have an age range between 20-49 years; The highest frequency of dyslipidemia is seen at older ages, a statistically significant relationship was found (p=0.048) between age and the presence of dyslipidemia; 128 (61%) of the patients are below 4 years of illness time; 188 (90%) belonged to scheme I (without IP) and 21 (10%) to scheme II (with PI) of HAART; 191 (91.4%) under 6 years of Tatga; 33 (60%) in AIDS stage presented dyslipidemia, no statistical relationship was found significant (p== 0.906) between the stage of the disease and the presence of dyslipidemia; 14 (66.7%) with ARGA containing busted PI presented dyslipidemia, while those who do not have the PI busted, 110 (58.5%) presented dyslipidemia; no relationship found statistically significant (p == 0.470) between the type of T ARGA and the presence of dyslipidemia. In conclusion: The prevalence of dyslipidemia in patients infected with HIV and in HAART, treated at the Loreto Regional Hospital, was 59.3%. The average age of the patients was 36 years; 70% of the patients are male, 27.3% of Patients are male and present a type of dyslipidemia Hypertriglyceridemia; 30.1% belong to HAART scheme I and type of dyslipidemia Hypertriglyceridemia; 15.8% of patients have 1 to 2 years of T ARGA time and They belong to the Hypertriglyceridemia type of dyslipidernia. There is no association between scheme T ARG A, T ARGA time and the type of dyslipidernia.
This item is licensed under a Creative Commons License